On Thursday last week, the Trump administration cancelled around 90% of contracts funded by the U.S. Agency for International ...

BioNTech said in a regulatory filing on Tuesday the U.S. Food and Drug Administration has placed a clinical hold on an ...

Lema Tefera's voice broke as he described losing four children to malaria in just one month -- deaths that could likely have ...

2. In Ethiopia, food assistance stopped for more than 1 million people, according to the Tigray Disaster Risk Management ...

Hundreds of people have tested positive for malaria in northwest Congo as health officials try to understand what is behind ...

Can a drug that's used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have ...

The vaccine space has been battered by strong headwinds in recent weeks, including high-level disruptions to FDA and CDC ...

Antimalarial drug resistance is a pressing issue in combating the spread of malaria worldwide. In a new study, researchers from Children's Hospital of Philadelphia (CHOP) discovered a key process ...

The FDA has ordered BioNTech to immediately halt its Phase I/II trial of malaria vaccine candidate BNT165e, pending changes.

Lema Tefera's voice broke as he described losing four children to malaria in just one month — deaths that could likely have been prevented if not for the conflict in Ethiopia's Oromia region.

Malaria drug pyronaridine shows promise for treating cancer according to research led by UTEP's Renato Aguilera.

A condition that has killed at least 50 people in northwest Democratic Republic of Congo this month is suspected to be malaria or food poisoning, local health officials said on Thursday.